Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mjp
    Member
    • Mar 2011
    • 25

    #1

    mapping reads against luciferase with bowtie

    I have used bowtie to map my reads against Arabidopsis.

    I have also built a reference genome out of my luciferase gene sequence and did map my reads against that.

    I'm wondering whether building bowtie indexes out of that short sequence will affect my further analysis?

    Do you think that after applying the same way of normalization (in my case for total read number and for gene length) I will have comparable results between luciferase and Arabidopsis?

    In luciferase case my number of mapped reads will be equal to total reads mapped so doing this normalization does not make a lot of sense.

    RPKM maybe?
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    Comparing transcripts from one gene against transcripts mapped against a whole genome sounds a little bizarre. Maybe you need to explain what you're trying to achieve in the project ?

    Comment

    • mjp
      Member
      • Mar 2011
      • 25

      #3
      Luciferase is the control gene that I have used in my experiment. It is fused with the rd29a promoter. In my experiment luciferase level of expression should be at the very similar level as the rd29a gene as they share the same promoter.

      I would like to have a relative level of expression between luciferase and rd29a gene.

      I have mapped my reads against Arabidopsis genome so I have rd29a level of expression. Now I'm trying to figure out whether building reference genome with bowtie out of luciferase sequence and performing the mapping of my reads against that would give me something that I could compare with rd29a.

      Thanks.

      Comment

      • simonandrews
        Simon Andrews
        • May 2009
        • 870

        #4
        Personally I'd have been tempted to put the luciferase into the existing Arabidopsis genome (as an extra 'chromosome') so I could discount any possibility of non-specific matches being different between the two genomes you currently have. It may make no difference, but it will mean that you can get away with only doing a single search if nothing else.

        Comment

        • feixue1039
          Member
          • Mar 2011
          • 18

          #5
          Hi,mjp
          As I know,only the uniquely mapped reads are considered in the calculation of RPKM value. And a read uniquely map to luciferase gene sequence may map alternatively to many loci of your genome.So I advise you not to build bowtie indexes with the luciferase gene sequence only.
          Just my humble opinion.

          feixue1039

          Comment

          • mjp
            Member
            • Mar 2011
            • 25

            #6
            Thanks guys,

            I followed your ideas and built the one set of indices after including my luciferase genes as a separate chromosome. I actually included my entire plasmid as a separate chromosome.

            This step did not give me better results but they are more comparable now I think. I also found nice set of reads mapped in different regions of my plasmid which is somewhat backing up the luciferase mappings.

            Thanks once again.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              How Immunogenomics Decodes Immunity’s Genetic Blueprint
              by SEQadmin2




              The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

              This convergence of genetics, immunology, and computation...
              Today, 05:41 AM
            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 08-24-2026, 10:32 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-20-2026, 11:17 AM
            0 responses
            48 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-18-2026, 10:05 AM
            0 responses
            55 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-13-2026, 12:22 PM
            0 responses
            50 views
            0 reactions
            Last Post SEQadmin2  
            Working...